Reversibility of acute B-cell leukaemia induced by BCR-ABL1

Nature Genetics

Volumn 24, Issue 1, 2000, Pages 57-60

  Huettner, Claudia S ^a   Zhang, Pu ^a   Van Etten, Richard A ^a   Tenen, Daniel G ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; B CELL LEUKEMIA; CHROMOSOME TRANSLOCATION; CHRONIC MYELOID LEUKEMIA; EMBRYO DEVELOPMENT; GENE EXPRESSION; MOUSE; NONHUMAN; ONCOGENE; PRIORITY JOURNAL;

ADULT; ANIMALS; BONE MARROW CELLS; FUSION PROTEINS, BCR-ABL; HUMANS; IMMUNOBLOTTING; LEUKEMIA, B-CELL, ACUTE; MICE; MICE, TRANSGENIC; NEOPLASM TRANSPLANTATION;

ANIMALIA;

EID: 0033987718     PISSN: 10614036     EISSN: None     Source Type: Journal    
DOI: 10.1038/71691     Document Type: Article

References (27)

1. Nowell, P.C. & Hungerford, D.A. A minute chromosome in human chronic granulocytic leukemia. Science 132, 1197-1200 (1960).
2. Melo, J.V. The molecular biology of chronic myeloid leukaemia. Leukemia 10, 751-756 (1996).
3. Shtivelman, E., Lifshitz, B., Gale, R.P. & Canaani, E. Fused transcript of abl and bcr genes in chronic myelogenous leukaemia. Nature 315, 550-554 (1985).
4. Clark, S.S. et al. Expression of a distinctive BCR-ABL oncogene in Ph1-positive acute lymphocytic leukemia (ALL). Science 239, 775-777 (1988).
5. Van Etten, R.A. in Leukemia: Advances in Treatment and Research (eds Freireich, E.J. & Kantarjian, H.) 294-325 (Kluwer Academic, Norwood, 1993).
6. Heisterkamp, N. et al. Acute leukaemia in bcr/abl transgenic mice. Nature 344, 251-253 (1990).
7. Heisterkamp, N., Jenster, G., Kioussis, D., Pattengale, P.K. & Groffen, J. Human bcr-abl gene has a lethal effect on embryogenesis. Transgenic Res 1, 45-53 (1991).
8. Honda, H. et al. Expression of p210bcr/abl by metallothionein promoter induced T-cell leukemia in transgenic mice. Blood 85, 2853-2861 (1995).
9. Honda, H. et al. Development of acute lymphoblastic leukemia and myeloproliferative disorder in transgenic mice expressing p210(bcr/abl): a novel transgenic model for human Phi-positive leukemias. Blood 91, 2067-2075 (1998).
10. Castellanos, A. et al. A BCR-ABL(p190) fusion gene made by homologous recombination causes B-cell acute lymphoblastic leukemias in chimeric mice with independence of the endogenous bcr product. Blood 90, 2168-2174 (1997).
11. Furth, P.A. et al. Temporal control of gene expression in transgenic mice by a tetracycline-responsive promoter. Proc. Natl Acad. Sci. USA 91, 9302-9306 (1994).
12. Hennighausen, L., Wall, R.J., Tillmann, U., Li, M. & Furth, P.A. Conditional gene expression in secretory tissues and skin of transgenic mice using the MMTV-LTR and the tetracycline responsive system. J. Cell. Biochem. 59, 463-472 (1995).
13. Hardy, R.R., Carmack, C.E., Shinton, S.A., Kemp, J.D. & Hayakawa, K. Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow. J. Exp. Med. 173, 1213-1225 (1991).
14. Radomska, H.S. et al. Multiple control elements are required for expression of the human CD34 gene. Gene 222, 305-318 (1998).
15. Van Etten, R.A. in Medical Management of Chronic Myelogenous Leukemia (eds Talpaz, M. & Kantarjian, H.) 77-101 (Marcel Dekker, New York, 1998).
16. McGahon, A. et al. BCR-ABL maintains resistance of chronic myelogenous leukemia cells to apoptotic cell death, Blood 83, 1179-1187 (1994).
17. Bedi, A., Zehnbauer, B.A., Barber, J.P., Sharkis, S.J. & Jones, R.J. Inhibition of apoptosis by BCR-ABL in chronic myeloid leukemia. Blood 83, 2038-2044 (1994).
18. Chen, Y.Y. & Rosenberg, N. Lymphoid cells transformed by Abelson virus require the v-abl protein-tyrosine kinase only during early G1. Proc. Natl Acad. Sci. USA 89, 6683-6687 (1992).
19. Ewald, D. et al. Time-sensitive reversal of hyperplasia in transgenic mice expressing SV40 T antigen. Science 273, 1384-1386 (1996).
20. Druker, B.J. et al. Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells. Nature Med. 2, 561-566 (1996).
21. Daley, G.Q., Van Etten, R.A & Baltimore, D. Blast crisis in a murine model of chronic myelogenous leukemia. Proc Natl Acad. Sci. USA 88, 11335-11338 (1991).
22. Tanaka, M. & Herr, W. Differential transcriptional activation by Oct-1 and Oct-2: interdependent activation domains induce Oct-2 phosphorylation. Cell 60, 375-386(1990).
23. Cross, N.C. et al. Minimal residual disease after allogeneic bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: correlations with acute graft-versus-host disease and relapse. Br. J. Haematol. 84, 67-74 (1993)
24. Kraig, E. et al. T and B cells that recognized the same antigen do not transcribe similar heavy chain variable region gene segments. J. Exp. Med. 158, 192-209 (1983)
25. Leder, A., Pattengale, P.K., Kuo, A., Stewart, T.A. & Leder, P. Consequences of widespread deregulation of the c-myc gene in transgenic mice: multiple neoplasms and normal development. Cell 45, 485-495 (1986).
26. Ilaria, R.L. Jr & Van Etten, R.A. The SH2 domain of P210BCR/ABL is not required for the transformation of hematopoietic factor-dependent cells. Blood 86, 3897-3904 (1995).
27. Gavrieli, Y., Sherman, Y. & Ben-Sasson, S.A. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell. Biol. 119, 493-501 (1992).